Drug profile · INN
tazarotene
TAZAROTENE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
tazarotene (TAZAROTENE) is an FDA-listed pharmaceutical active ingredient. Associated with Almirall. Route of administration: topical. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12065479
Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof
granted -
US 11979133
Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof
granted -
US 11920169
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11608492
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11331332
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
granted -
US 11311574
Methods and compositions for targeted cleavage and recombination
granted -
US 11206005
Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof
granted -
US 11149321
Methods and compositions for targeted single-stranded cleavage and targeted integration
granted
Frequently asked questions
What is tazarotene?
tazarotene (TAZAROTENE) is an FDA-listed pharmaceutical active ingredient. Associated with Almirall. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for tazarotene?
TAZAROTENE is a marketed brand name for tazarotene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tazarotene?
tazarotene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.